← All organizations
Highest phase reached
Phase 4
First clinical trial
Jun 1, 2011Last known activity
Nov 1, 2021
Timeline
1920s
- Jan 1, 1924
Institut de Cancérologie de Lorraine— Founded
Drugs by trial phase (17 distinct, 11 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (5 own, 0 via acquisition)
Phase 2 (11 own, 0 via acquisition)
Indications
Recent trials (20)
- NCT05104099Lead sponsorPhase 2Nov 1, 2021
- NCT05104099Overall official - principal investigatorPhase 2Nov 1, 2021
- NCT04827030Overall official - principal investigatorPhase 4Jun 28, 2021
- NCT03755895Lead sponsorPhase 2Nov 2, 2019
- NCT03755895Overall official - principal investigatorPhase 2Nov 2, 2019
- NCT02898376Overall official - principal investigatorPhase 3Sep 1, 2017
- NCT02898376Lead sponsorPhase 3Sep 1, 2017
- NCT02997553Lead sponsorPhase 3Jun 1, 2017
- NCT02997553Overall official - principal investigatorPhase 3Jun 1, 2017
- NCT02920216Overall official - principal investigatorN/ADec 1, 2016
- NCT02920216Lead sponsorN/ADec 1, 2016
- NCT02822625Lead sponsorPhase 3Aug 1, 2016
- NCT02822625Overall official - principal investigatorPhase 3Aug 1, 2016
- NCT02676349Overall official - principal investigatorPhase 2Jun 1, 2016
- NCT02676349Lead sponsorPhase 2Jun 1, 2016
Details
- Founded
- Vandœuvre-lès-Nancy, FR Jan 1, 1924
- Last known activity
- Nov 1, 2021